Molecure S.A.

WSE:MOC Stock Report

Market Cap: zł166.7m

Molecure Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Marcin Szumowski

Chief executive officer

zł473.2k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.7%
Management average tenure3.8yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Aug 20
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

CEO

Marcin Szumowski

no data

Tenure

zł473,205

Compensation

Dr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...

Leadership Team

NamePositionTenureCompensationOwnership
Marcin Szumowski
Co-Founderno datazł473.21k0.70%
PLN 1.2m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł421.09k0.20%
PLN 341.6k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.8yrszł473.21k0.11%
PLN 187.0k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.8yrszł348.41k0.034%
PLN 57.4k
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.8yrszł500.00k3.01%
PLN 5.0m
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno datano datano data
Piotr Iwanowski
Chief Medical Officer & Member of Management Boardless than a yearno datano data
Magdalena Tyszkiewicz
Head of CMC4.8yrsno datano data
Marta Borkowska
Director of the Management Board Office2.8yrsno datano data

3.8yrs

Average Tenure

Experienced Management: MOC's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Luke O'Neill
Member of Scientific Advisory Boardno datano datano data
Bart Lambrecht
Member of Scientific Advisory Boardno datano datano data
Tomasz Piec
Vice Chairman of the Supervisory Board4.8yrszł133.62kno data
Douglas Hay
Member of Scientific Advisory Boardno datano datano data
Paul Van Der Horst
Independent Chairman of the Supervisory Board2.8yrszł132.99k0.059%
PLN 99.0k
Nancy Van Osselaer
Independent Member of the Supervisory Board2.8yrszł124.22kno data
Agnieszka Motyl
Member of the Supervisory Board1.3yrszł44.45kno data
Pawel Trawkowski
Independent Member of the Supervisory Board2.4yrszł124.22kno data

2.8yrs

Average Tenure

Experienced Board: MOC's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.